New-onset COVID-19-related Diabetes: an Early Indicator of Multi-organ Injury and Mortally of SARS-CoV-2 Infection

Overview

Journal Curr Med (Cham)

Specialty General Medicine

Date 2022 Jun 8

PMID 35673632

Authors

Jin-Kui Yang

Miao-Miao Zhao

Jian-Min Jin

Shi Liu

Peng Bai

Wei He

Fei Wu

Xiao-Fang Liu

Zhong-Lin Chai

De-Min Han

Affiliations

Soon will be listed here.

Abstract

Objective: The pandemic of 2019 coronavirus (SARS-CoV-2) disease (COVID-19) has imposed a severe public health burden worldwide. Most patients with COVID-19 were mild. Severe patients progressed rapidly to critical condition including acute respiratory distress syndrome (ARDS), multi-organ failure and even death. This study aims to find early multi-organ injury indicators and blood glucose for predicting mortality of COVID-19.

Methods: Fasting blood glucose (FBG) ≥7.0 mmol/L for two times during hospitalization and without a history of diabetes were defined as new-onset COVID-19-related diabetes (CRD). Indicators of injuries for multiple organs, including the lung, heart, kidney and liver, and glucose homeostasis were specifically analyzed for predicting death.

Results: A total of 120 patients with a severity equal to or greater than were hospitalized. After excluding patients with history of diabetes, chronic heart, kidney, and liver disease, 69 patients were included in the final analysis. Of the 69 patients, 23 were , 20 were , and 26 were (including 16 deceased patients). Univariable analysis indicated that CRD, lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBDH), creatine kinase (CK) and creatinine (Cr) were associated with death. Multivariable analysis indicated that CRD was an independent predictor for death (HR = 3.75, 95% CI 1.26-11.15). Abnormal glucose homeostasis or CRD occurred earlier than other indicators for predicting poor outcomes. Indicators of multiple organ injury were in parallel with the expression patterns of ACE2 (the SARS-CoV-2 receptor) in different organs including pancreatic islet.

Conclusions: New-onset COVID-19-related diabetes is an early indicator of multi-organ injury and predictor for poor outcomes and death in COVID-19 patients. As it is easy to perform for clinical practices and self-monitoring, glucose testing will be helpful for predicting poor outcomes to facilitate appropriate intensive care.

Citing Articles

Machine learning based prediction models for the prognosis of COVID-19 patients with DKA.

Xiang Z, Hu J, Bu S, Ding J, Chen X, Li Z Sci Rep. 2025; 15(1):2633.

PMID: 39837852 PMC: 11751332. DOI: 10.1038/s41598-025-85357-9.

Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia.

Mohamed A, Darraj M, Yassin A, Somaili M, Sayed A, Oraibi O BMC Endocr Disord. 2024; 24(1):197.

PMID: 39304825 PMC: 11414278. DOI: 10.1186/s12902-024-01724-z.

Interferon Upregulation Associates with Insulin Resistance in Humans.

Adeva-Andany M, Carneiro-Freire N, Castro-Quintela E, Ameneiros-Rodriguez E, Adeva-Contreras L, Fernandez-Fernandez C Curr Diabetes Rev. 2024; 21(3):86-105.

PMID: 38500280 DOI: 10.2174/0115733998294022240309105112.

Factors associated with bleeding complications in patients with coronavirus disease 2019 admitted to intensive care units: A multicenter retrospective cohort study.

Imai D, Ushigome E, Hamaguchi M, Hashimoto S, Fukui M J Diabetes Investig. 2023; 14(11):1312-1317.

PMID: 37581471 PMC: 10583641. DOI: 10.1111/jdi.14068.

New-onset and relapsed Graves' disease following COVID-19 vaccination: a comprehensive review of reported cases.

Chen K, Gao Y, Li J Eur J Med Res. 2023; 28(1):232.

PMID: 37443067 PMC: 10339579. DOI: 10.1186/s40001-023-01210-7.

References

Inciardi R, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D . Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):819-824. PMC: 7364333. DOI: 10.1001/jamacardio.2020.1096. View

Yang J, Lin S, Ji X, Guo L . Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2009; 47(3):193-9. PMC: 7088164. DOI: 10.1007/s00592-009-0109-4. View

Wu K, Lu S, Changchien C, Chiu K, Kuo C, Chuah S . Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome. Am J Trop Med Hyg. 2004; 71(2):125-8. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Xu L, Liu J, Lu M, Yang D, Zheng X . Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020; 40(5):998-1004. PMC: 7228361. DOI: 10.1111/liv.14435. View

Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View

Gupta D, Krueger C, Lastra G . Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction. Curr Diabetes Rev. 2012; 8(2):76-83. DOI: 10.2174/157339912799424564. View

Yang J, Feng Y, Yuan M, Yuan S, Fu H, Wu B . Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006; 23(6):623-8. DOI: 10.1111/j.1464-5491.2006.01861.x. View

Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H . Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2):631-7. PMC: 7167720. DOI: 10.1002/path.1570. View

10.

Prasad N, Novak J, Patel M . Kidney Diseases Associated With Parvovirus B19, Hanta, Ebola, and Dengue Virus Infection: A Brief Review. Adv Chronic Kidney Dis. 2019; 26(3):207-219. DOI: 10.1053/j.ackd.2019.01.006. View

11.

Fang H, Yang J . Tissue-specific pattern of angiotensin-converting enzyme 2 expression in rat pancreas. J Int Med Res. 2010; 38(2):558-69. DOI: 10.1177/147323001003800218. View

12.

Cui Y, Tian M, Huang D, Wang X, Huang Y, Fan L . A 55-Day-Old Female Infant Infected With 2019 Novel Coronavirus Disease: Presenting With Pneumonia, Liver Injury, and Heart Damage. J Infect Dis. 2020; 221(11):1775-1781. PMC: 7184483. DOI: 10.1093/infdis/jiaa113. View

13.

Pollack A, Kontorovich A, Fuster V, Dec G . Viral myocarditis--diagnosis, treatment options, and current controversies. Nat Rev Cardiol. 2015; 12(11):670-80. DOI: 10.1038/nrcardio.2015.108. View

14.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

15.

Dungan K, Braithwaite S, Preiser J . Stress hyperglycaemia. Lancet. 2009; 373(9677):1798-807. PMC: 3144755. DOI: 10.1016/S0140-6736(09)60553-5. View

16.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

17.

Lang Z, Zhang L, Zhang S, Meng X, Li J, Song C . Pathological study on severe acute respiratory syndrome. Chin Med J (Engl). 2003; 116(7):976-80. View

18.

Riski H, Hovi T, FRICK M . Carditis associated with coronavirus infection. Lancet. 1980; 2(8185):100-1. PMC: 7135548. DOI: 10.1016/s0140-6736(80)92989-x. View

19.

Yao X, Li T, He Z, Ping Y, Liu H, Yu S . [A pathological report of three COVID-19 cases by minimal invasive autopsies]. Zhonghua Bing Li Xue Za Zhi. 2020; 49(5):411-417. DOI: 10.3760/cma.j.cn112151-20200312-00193. View

20.

Mackay I, Arden K . MERS coronavirus: diagnostics, epidemiology and transmission. Virol J. 2015; 12:222. PMC: 4687373. DOI: 10.1186/s12985-015-0439-5. View